Indoles-A Targeting the PI3K/Akt/mTOR Pathway: Recent Advances in Strategic Design, Mechanism, and Future...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Oncology

Background:

• Indole derivatives are a versatile class of compounds with significant potential in cancer therapy.
• The PI3K/Akt/mTOR pathway is frequently dysregulated in various cancers, making it a key therapeutic target.
• Indole scaffolds allow for the design of potent and selective inhibitors of this pathway.

Purpose of the Study:

• To review recent advancements in the design, synthesis, and biological evaluation of indole derivatives as anticancer agents.
• To explore the mechanisms of action, including kinase inhibition and apoptosis induction.
• To discuss structure-activity relationships and synthetic strategies for drug development.

Main Methods:

• Literature review of recent studies on indole derivatives in cancer research.
• Analysis of synthetic approaches for generating novel indole-based compounds.
• Evaluation of biological activity data, including cytotoxic effects and pathway inhibition.

Main Results:

• Indole derivatives demonstrate potent anticancer activity through various mechanisms, notably PI3K/Akt/mTOR pathway inhibition.
• Structure-activity relationship studies provide insights for optimizing drug candidates.
• Both natural and synthetic indole derivatives exhibit promising cytotoxic effects against diverse cancer cell lines.

Conclusions:

• Indole derivatives represent a valuable scaffold for developing targeted anticancer drugs with improved specificity and reduced toxicity.
• Their ability to act as multitarget agents, particularly through PI3K/Akt/mTOR pathway modulation, offers therapeutic advantages.
• Further investigation into indole derivatives holds promise for advancing precision cancer therapy.